Pluristem Therapeutics, Inc. (NASDAQ:PSTI) – Scientific Study Published in … – Benzinga
|
Pluristem Therapeutics, Inc. (NASDAQ:PSTI) – Scientific Study Published in …
Benzinga Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced the publication of a scientific study regarding PLacental eXpanded (PLX) cells in the prominent peer-reviewed journal Stem Cells. The paper, titled "Mesenchymal stromal cells prevent … New Data Show Pluristem's PLX Cells Regulate the Immune System – CNN Money |
